BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mestecky J, Russell MW, Elson CO. Perspectives on mucosal vaccines: is mucosal tolerance a barrier? J Immunol 2007;179:5633-8. [PMID: 17947632 DOI: 10.4049/jimmunol.179.9.5633] [Cited by in Crossref: 109] [Cited by in F6Publishing: 102] [Article Influence: 7.3] [Reference Citation Analysis]
Number Citing Articles
1 Van der Weken H, Cox E, Devriendt B. Advances in Oral Subunit Vaccine Design. Vaccines (Basel) 2020;9:1. [PMID: 33375151 DOI: 10.3390/vaccines9010001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
2 Lee CM, Chen CY, Chien RN, Tseng KC, Peng CY, Tung SY, Fang YJ, Huang YH, Lu SN, Hung CH, Tsai TJ, Fang CC, Hsu CW, Yeh CT. A double-blind randomized controlled study to evaluate the efficacy of low-dose oral interferon-alpha in preventing hepatitis C relapse. J Interferon Cytokine Res 2014;34:187-94. [PMID: 24237300 DOI: 10.1089/jir.2013.0074] [Reference Citation Analysis]
3 Iqbal S, Zebeli Q, Mansmann DA, Dunn SM, Ametaj BN. Oral administration of LPS and lipoteichoic acid prepartum modulated reactants of innate and humoral immunity in periparturient dairy cows. Innate Immun 2014;20:390-400. [PMID: 23941759 DOI: 10.1177/1753425913496125] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
4 Azizi A, Kumar A, Diaz-Mitoma F, Mestecky J. Enhancing oral vaccine potency by targeting intestinal M cells. PLoS Pathog 2010;6:e1001147. [PMID: 21085599 DOI: 10.1371/journal.ppat.1001147] [Cited by in Crossref: 114] [Cited by in F6Publishing: 106] [Article Influence: 9.5] [Reference Citation Analysis]
5 Mestecky J, Russell MW. Specific antibody activity, glycan heterogeneity and polyreactivity contribute to the protective activity of S-IgA at mucosal surfaces. Immunol Lett 2009;124:57-62. [PMID: 19524784 DOI: 10.1016/j.imlet.2009.03.013] [Cited by in Crossref: 62] [Cited by in F6Publishing: 56] [Article Influence: 4.8] [Reference Citation Analysis]
6 Risso GS, Carabajal MV, Bruno LA, Ibañez AE, Coria LM, Pasquevich KA, Lee SJ, McSorley SJ, Briones G, Cassataro J. U-Omp19 from Brucella abortus Is a Useful Adjuvant for Vaccine Formulations against Salmonella Infection in Mice. Front Immunol 2017;8:171. [PMID: 28261222 DOI: 10.3389/fimmu.2017.00171] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
7 Vela Ramirez JE, Sharpe LA, Peppas NA. Current state and challenges in developing oral vaccines. Adv Drug Deliv Rev 2017;114:116-31. [PMID: 28438674 DOI: 10.1016/j.addr.2017.04.008] [Cited by in Crossref: 111] [Cited by in F6Publishing: 98] [Article Influence: 22.2] [Reference Citation Analysis]
8 Kapp K, Maul J, Hostmann A, Mundt P, Preiss JC, Wenzel A, Thiel A, Zeitz M, Ullrich R, Duchmann R. Modulation of systemic antigen-specific immune responses by oral antigen in humans. Eur J Immunol 2010;40:3128-37. [PMID: 20957752 DOI: 10.1002/eji.201040701] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
9 Kumar S, Sunagar R, Gosselin EJ. Preclinical Efficacy of a Trivalent Human FcγRI-Targeted Adjuvant-Free Subunit Mucosal Vaccine against Pulmonary Pneumococcal Infection. Vaccines (Basel) 2020;8:E193. [PMID: 32340134 DOI: 10.3390/vaccines8020193] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
10 Madani F, Hsein H, Busignies V, Tchoreloff P. An overview on dosage forms and formulation strategies for vaccines and antibodies oral delivery. Pharmaceutical Development and Technology 2020;25:133-48. [DOI: 10.1080/10837450.2019.1689402] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
11 Meshcheriakova AK, Kostinov MP, Magarshak OO, Guseva TS, Parshina OV. [The influence of gel-like recombinant interferon α-2b on the clinical course of acute respiratory infection and the state of mucosal immunity in the pregnant women]. Vestn Otorinolaringol 2014;:50-3. [PMID: 25734309 DOI: 10.17116/otorino2014650-53] [Cited by in Crossref: 3] [Article Influence: 0.4] [Reference Citation Analysis]
12 Sanchez-Guzman D, Le Guen P, Villeret B, Sola N, Le Borgne R, Guyard A, Kemmel A, Crestani B, Sallenave JM, Garcia-Verdugo I. Silver nanoparticle-adjuvanted vaccine protects against lethal influenza infection through inducing BALT and IgA-mediated mucosal immunity. Biomaterials 2019;217:119308. [PMID: 31279103 DOI: 10.1016/j.biomaterials.2019.119308] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 6.7] [Reference Citation Analysis]
13 Mestecky J, Raska M, Novak J, Alexander RC, Moldoveanu Z. Antibody-mediated protection and the mucosal immune system of the genital tract: relevance to vaccine design. J Reprod Immunol 2010;85:81-5. [PMID: 20236708 DOI: 10.1016/j.jri.2010.02.003] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 2.4] [Reference Citation Analysis]
14 Clarke JL, Paruch L, Dobrica MO, Caras I, Tucureanu C, Onu A, Ciulean S, Stavaru C, Eerde A, Wang Y, Steen H, Haugslien S, Petrareanu C, Lazar C, Popescu CI, Bock R, Dubuisson J, Branza-Nichita N. Lettuce-produced hepatitis C virus E1E2 heterodimer triggers immune responses in mice and antibody production after oral vaccination. Plant Biotechnol J 2017;15:1611-21. [PMID: 28419665 DOI: 10.1111/pbi.12743] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 5.6] [Reference Citation Analysis]
15 Kuehn CC, Oliveira LGR, Miranda MA, Prado JC. Distinctive histopathology and modulation of cytokine production during oral and intraperitoneal Trypanosoma cruzi Y strain infection. Parasitology 2014;141:904-13. [DOI: 10.1017/s0031182013002059] [Cited by in Crossref: 3] [Article Influence: 0.4] [Reference Citation Analysis]
16 Lemoine C, Thakur A, Krajišnik D, Guyon R, Longet S, Razim A, Górska S, Pantelić I, Ilić T, Nikolić I, Lavelle EC, Gamian A, Savić S, Milicic A. Technological Approaches for Improving Vaccination Compliance and Coverage. Vaccines (Basel) 2020;8:E304. [PMID: 32560088 DOI: 10.3390/vaccines8020304] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
17 Takahashi K, Orito N, Tokunoh N, Inoue N. Current issues regarding the application of recombinant lactic acid bacteria to mucosal vaccine carriers. Appl Microbiol Biotechnol 2019;103:5947-55. [PMID: 31175431 DOI: 10.1007/s00253-019-09912-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
18 Mestecky J, Nguyen H, Czerkinsky C, Kiyono H. Oral immunization: an update. Curr Opin Gastroenterol 2008;24:713-9. [PMID: 19122521 DOI: 10.1097/MOG.0b013e32830d58be] [Cited by in Crossref: 53] [Cited by in F6Publishing: 18] [Article Influence: 4.1] [Reference Citation Analysis]
19 Shalash AO, Hussein WM, Skwarczynski M, Toth I. Hookworm infection: Toward development of safe and effective peptide vaccines. J Allergy Clin Immunol 2021;148:1394-1419.e6. [PMID: 34872650 DOI: 10.1016/j.jaci.2021.10.013] [Reference Citation Analysis]
20 Kozlowski PA, Aldovini A. Mucosal Vaccine Approaches for Prevention of HIV and SIV Transmission. Curr Immunol Rev 2019;15:102-22. [PMID: 31452652 DOI: 10.2174/1573395514666180605092054] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 5.0] [Reference Citation Analysis]
21 Kumar A, Thotakura PL, Tiwary BK, Krishna R. Target identification in Fusobacterium nucleatum by subtractive genomics approach and enrichment analysis of host-pathogen protein-protein interactions. BMC Microbiol. 2016;16:84. [PMID: 27176600 DOI: 10.1186/s12866-016-0700-0] [Cited by in Crossref: 31] [Cited by in F6Publishing: 22] [Article Influence: 5.2] [Reference Citation Analysis]
22 Mann JF, Acevedo R, Campo JD, Pérez O, Ferro VA. Delivery systems: a vaccine strategy for overcoming mucosal tolerance? Expert Rev Vaccines 2009;8:103-12. [PMID: 19093777 DOI: 10.1586/14760584.8.1.103] [Cited by in Crossref: 44] [Cited by in F6Publishing: 43] [Article Influence: 3.4] [Reference Citation Analysis]
23 Zhang X, Dervillez X, Chentoufi AA, Badakhshan T, Bettahi I, Benmohamed L. Targeting the genital tract mucosa with a lipopeptide/recombinant adenovirus prime/boost vaccine induces potent and long-lasting CD8+ T cell immunity against herpes: importance of MyD88. J Immunol 2012;189:4496-509. [PMID: 23018456 DOI: 10.4049/jimmunol.1201121] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 3.1] [Reference Citation Analysis]
24 Paul M, Ma JK. Plant-made immunogens and effective delivery strategies. Expert Review of Vaccines 2014;9:821-33. [DOI: 10.1586/erv.10.88] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 2.8] [Reference Citation Analysis]
25 Wang N, Wang T, Zhang M, Chen R, Deng Y. Using procedure of emulsification-lyophilization to form lipid A-incorporating cochleates as an effective oral mucosal vaccine adjuvant-delivery system (VADS). Int J Pharm 2014;468:39-49. [PMID: 24704308 DOI: 10.1016/j.ijpharm.2014.04.002] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
26 Timofeeva A, Sedykh S, Nevinsky G. Post-Immune Antibodies in HIV-1 Infection in the Context of Vaccine Development: A Variety of Biological Functions and Catalytic Activities. Vaccines 2022;10:384. [DOI: 10.3390/vaccines10030384] [Reference Citation Analysis]
27 Yang W, Cong Y. Gut microbiota-derived metabolites in the regulation of host immune responses and immune-related inflammatory diseases. Cell Mol Immunol 2021;18:866-77. [PMID: 33707689 DOI: 10.1038/s41423-021-00661-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
28 Lee JY, Xu ML, Kim HJ, Kang HA, Kim H. A comparative study of the adjuvanticity of Hansenula polymorpha, Saccharomyces cerevsiae and Yarrowia lipolytica in oral and nasal immunization with virus capsid antigens. Biotechnol Lett 2013;35:1881-8. [DOI: 10.1007/s10529-013-1273-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
29 Sivick KE, Mobley HL. Waging war against uropathogenic Escherichia coli: winning back the urinary tract. Infect Immun 2010;78:568-85. [PMID: 19917708 DOI: 10.1128/IAI.01000-09] [Cited by in Crossref: 150] [Cited by in F6Publishing: 78] [Article Influence: 11.5] [Reference Citation Analysis]
30 Ferreira PC, da Silva JB, Piazza RM, Eckmann L, Ho PL, Oliveira ML. Immunization of mice with Lactobacillus casei expressing a beta-intimin fragment reduces intestinal colonization by Citrobacter rodentium. Clin Vaccine Immunol 2011;18:1823-33. [PMID: 21900533 DOI: 10.1128/CVI.05262-11] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
31 Travis CR. As Plain as the Nose on Your Face: The Case for A Nasal (Mucosal) Route of Vaccine Administration for Covid-19 Disease Prevention. Front Immunol 2020;11:591897. [PMID: 33117404 DOI: 10.3389/fimmu.2020.591897] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
32 Soheili H, Abolhassani H, Arandi N, Khazaei HA, Shahinpour S, Hirbod-mobarakeh A, Rezaei N, Aghamohammadi A. Evaluation of Natural Regulatory T Cells in Subjects with Selective IgA Deficiency: From Senior Idea to Novel Opportunities. Int Arch Allergy Immunol 2013;160:208-14. [DOI: 10.1159/000339867] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 2.3] [Reference Citation Analysis]
33 Curtiss R. Antigen Delivery System II. Mucosal Immunology. Elsevier; 2015. pp. 1233-69. [DOI: 10.1016/b978-0-12-415847-4.00064-1] [Cited by in Crossref: 4] [Article Influence: 0.6] [Reference Citation Analysis]
34 Wang L, Coppel RL. Oral vaccine delivery: can it protect against non-mucosal pathogens? Expert Rev Vaccines 2008;7:729-38. [PMID: 18665772 DOI: 10.1586/14760584.7.6.729] [Cited by in Crossref: 29] [Cited by in F6Publishing: 22] [Article Influence: 2.1] [Reference Citation Analysis]
35 Yuki Y, Kiyono H. Mucosal vaccines: novel advances in technology and delivery. Expert Rev Vaccines 2009;8:1083-97. [PMID: 19627189 DOI: 10.1586/erv.09.61] [Cited by in Crossref: 72] [Cited by in F6Publishing: 65] [Article Influence: 5.5] [Reference Citation Analysis]
36 Russell MW, Mestecky J. Mucosal Vaccines. Mucosal Immunology. Elsevier; 2015. pp. 1039-46. [DOI: 10.1016/b978-0-12-415847-4.00055-0] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
37 Zhen Y, Wang N, Gao Z, Ma X, Wei B, Deng Y, Wang T. Multifunctional liposomes constituting microneedles induced robust systemic and mucosal immunoresponses against the loaded antigens via oral mucosal vaccination. Vaccine 2015;33:4330-40. [PMID: 25858854 DOI: 10.1016/j.vaccine.2015.03.081] [Cited by in Crossref: 34] [Cited by in F6Publishing: 31] [Article Influence: 4.9] [Reference Citation Analysis]
38 del Rio B, Dattwyler RJ, Aroso M, Neves V, Meirelles L, Seegers JF, Gomes-Solecki M. Oral immunization with recombinant lactobacillus plantarum induces a protective immune response in mice with Lyme disease. Clin Vaccine Immunol 2008;15:1429-35. [PMID: 18632920 DOI: 10.1128/CVI.00169-08] [Cited by in Crossref: 50] [Cited by in F6Publishing: 30] [Article Influence: 3.6] [Reference Citation Analysis]
39 Snelgrove RJ, Goulding J, Didierlaurent AM, Lyonga D, Vekaria S, Edwards L, Gwyer E, Sedgwick JD, Barclay AN, Hussell T. A critical function for CD200 in lung immune homeostasis and the severity of influenza infection. Nat Immunol. 2008;9:1074-1083. [PMID: 18660812 DOI: 10.1038/ni.1637] [Cited by in Crossref: 278] [Cited by in F6Publishing: 271] [Article Influence: 19.9] [Reference Citation Analysis]
40 Bhowmik T, D’souza B, Uddin MN, D’souza MJ. Oral delivery of microparticles containing plasmid DNA encoding hepatitis-B surface antigen. Journal of Drug Targeting 2012;20:364-71. [DOI: 10.3109/1061186x.2012.662686] [Cited by in Crossref: 16] [Cited by in F6Publishing: 4] [Article Influence: 1.6] [Reference Citation Analysis]
41 Wagnerova A, Babickova J, Liptak R, Celec P, Gardlik R. Beneficial effects of live and dead Salmonella -based vector strain on the course of colitis in mice. Lett Appl Microbiol 2016;63:340-6. [DOI: 10.1111/lam.12632] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
42 Park JH, Lee HK. Delivery Routes for COVID-19 Vaccines. Vaccines (Basel) 2021;9:524. [PMID: 34069359 DOI: 10.3390/vaccines9050524] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
43 Polak D, Benzki-Namdar E, Houri-Haddad Y, Shapira L. Mucosal vaccination shapes the expression of salivary antibodies and establishment of CD8+ T-cells. J Periodontol 2014;85:991-7. [PMID: 24359165 DOI: 10.1902/jop.2013.130470] [Reference Citation Analysis]
44 Fahmy TM, Demento SL, Caplan MJ, Mellman I, Saltzman WM. Design opportunities for actively targeted nanoparticle vaccines. Nanomedicine (Lond) 2008;3:343-55. [PMID: 18510429 DOI: 10.2217/17435889.3.3.343] [Cited by in Crossref: 67] [Cited by in F6Publishing: 68] [Article Influence: 4.8] [Reference Citation Analysis]
45 Fousteri G, Dave A, Morin B, Omid S, Croft M, von Herrath MG. Nasal cardiac myosin peptide treatment and OX40 blockade protect mice from acute and chronic virally-induced myocarditis. J Autoimmun 2011;36:210-20. [PMID: 21333491 DOI: 10.1016/j.jaut.2011.01.006] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 2.1] [Reference Citation Analysis]
46 Devriendt B, De Geest BG, Cox E. Designing oral vaccines targeting intestinal dendritic cells. Expert Opinion on Drug Delivery 2011;8:467-83. [DOI: 10.1517/17425247.2011.561312] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
47 Azegami T, Yuki Y, Kiyono H. Challenges in mucosal vaccines for the control of infectious diseases. International Immunology 2014;26:517-28. [DOI: 10.1093/intimm/dxu063] [Cited by in Crossref: 59] [Cited by in F6Publishing: 54] [Article Influence: 7.4] [Reference Citation Analysis]
48 Okayasu H, Sutter RW, Czerkinsky C, Ogra PL. Mucosal immunity and poliovirus vaccines: Impact on wild poliovirus infection and transmission. Vaccine 2011;29:8205-14. [DOI: 10.1016/j.vaccine.2011.08.059] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 2.5] [Reference Citation Analysis]
49 Collins MH, Craft JM, Bustamante JM, Tarleton RL. Oral exposure to Trypanosoma cruzi elicits a systemic CD8⁺ T cell response and protection against heterotopic challenge. Infect Immun 2011;79:3397-406. [PMID: 21628516 DOI: 10.1128/IAI.01080-10] [Cited by in Crossref: 27] [Cited by in F6Publishing: 17] [Article Influence: 2.5] [Reference Citation Analysis]
50 Gray WL. Recombinant varicella-zoster virus vaccines as platforms for expression of foreign antigens. Adv Virol 2013;2013:219439. [PMID: 23843791 DOI: 10.1155/2013/219439] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
51 Poles J, Alvarez Y, Hioe CE. Induction of intestinal immunity by mucosal vaccines as a means of controlling HIV infection. AIDS Res Hum Retroviruses 2014;30:1027-40. [PMID: 25354023 DOI: 10.1089/aid.2014.0233] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
52 Martinsson K, Johansson A, Kastbom A, Skogh T. Immunoglobulin (Ig)G1 and IgG4 anti-cyclic citrullinated peptide (CCP) associate with shared epitope, whereas IgG2 anti-CCP associates with smoking in patients with recent-onset rheumatoid arthritis (the Swedish TIRA project). Clin Exp Immunol 2017;188:53-62. [PMID: 27859022 DOI: 10.1111/cei.12901] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
53 Brazdova A, Senechal H, Peltre G, Poncet P. Immune Aspects of Female Infertility. Int J Fertil Steril 2016;10:1-10. [PMID: 27123194 DOI: 10.22074/ijfs.2016.4762] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
54 Timothy AA, Tokanovic A, Snibson KJ, Edwards SJ, Pearse MJ, Scheerlinck JP, Sutton P. ISCOMATRIX™ adjuvant reduces mucosal tolerance for effective pulmonary vaccination against influenza. Hum Vaccin Immunother 2015;11:377-85. [PMID: 25692970 DOI: 10.4161/21645515.2014.990859] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
55 Mestecky J, Alexander RC, Wei Q, Moldoveanu Z. Methods for evaluation of humoral immune responses in human genital tract secretions. Am J Reprod Immunol 2011;65:361-7. [PMID: 21087333 DOI: 10.1111/j.1600-0897.2010.00923.x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
56 Gorain C, Singh A, Bhattacharyya S, Kundu A, Lahiri A, Gupta S, Mallick AI. Mucosal delivery of live Lactococcus lactis expressing functionally active JlpA antigen induces potent local immune response and prevent enteric colonization of Campylobacter jejuni in chickens. Vaccine 2020;38:1630-42. [PMID: 31932136 DOI: 10.1016/j.vaccine.2019.12.064] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
57 Corthésy B. Role of secretory immunoglobulin A and secretory component in the protection of mucosal surfaces. Future Microbiol 2010;5:817-29. [PMID: 20441552 DOI: 10.2217/fmb.10.39] [Cited by in Crossref: 72] [Cited by in F6Publishing: 64] [Article Influence: 6.0] [Reference Citation Analysis]
58 Jang YS. A bacterium's guide to orienteering in the intestinal lumen. Interview by Emma Louise Walton. Microbes Infect 2013;15:845-8. [PMID: 24140556 DOI: 10.1016/j.micinf.2013.10.004] [Reference Citation Analysis]
59 Scerbo MJ, Rupil LL, Bibolini MJ, Roth GA, Monferran CG. Protective effect of a synapsin peptide genetically fused to the B subunit of Escherichia coli heat-labile enterotoxin in rat autoimmune encephalomyelitis. J Neurosci Res 2009;87:2273-81. [DOI: 10.1002/jnr.22048] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
60 Bielinska AU, Makidon PE, Janczak KW, Blanco LP, Swanson B, Smith DM, Pham T, Szabo Z, Kukowska-Latallo JF, Baker JR Jr. Distinct pathways of humoral and cellular immunity induced with the mucosal administration of a nanoemulsion adjuvant. J Immunol 2014;192:2722-33. [PMID: 24532579 DOI: 10.4049/jimmunol.1301424] [Cited by in Crossref: 37] [Cited by in F6Publishing: 33] [Article Influence: 4.6] [Reference Citation Analysis]
61 Azizi A, Ghunaim H, Diaz-mitoma F, Mestecky J. Mucosal HIV vaccines: A holy grail or a dud? Vaccine 2010;28:4015-26. [DOI: 10.1016/j.vaccine.2010.04.018] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 2.3] [Reference Citation Analysis]
62 Pniewski T, Kapusta J, Bociąg P, Kostrzak A, Fedorowicz-Strońska O, Czyż M, Gdula M, Krajewski P, Wolko B, Płucienniczak A. Plant expression, lyophilisation and storage of HBV medium and large surface antigens for a prototype oral vaccine formulation. Plant Cell Rep 2012;31:585-95. [PMID: 22246107 DOI: 10.1007/s00299-011-1223-7] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
63 Hellfritzsch M, Scherließ R. Mucosal Vaccination via the Respiratory Tract. Pharmaceutics 2019;11:E375. [PMID: 31374959 DOI: 10.3390/pharmaceutics11080375] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 6.0] [Reference Citation Analysis]
64 Campo JD, Zayas C, Romeu B, Acevedo R, González E, Bracho G, Cuello M, Cabrera O, Balboa J, Lastre M. Mucosal immunization using proteoliposome and cochleate structures from Neisseria meningitidis serogroup B induce mucosal and systemic responses. Methods 2009;49:301-8. [PMID: 19410000 DOI: 10.1016/j.ymeth.2009.03.025] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 1.8] [Reference Citation Analysis]
65 Zhao W, Zhao Z, Russell MW. Characterization of antigen-presenting cells induced by intragastric immunization with recombinant chimeric immunogens constructed from Streptococcus mutans AgI/II and type I or type II heat-labile enterotoxins. Mol Oral Microbiol 2011;26:200-9. [PMID: 21545697 DOI: 10.1111/j.2041-1014.2011.00608.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
66 Lee Y, Kamada N, Moon JJ. Oral nanomedicine for modulating immunity, intestinal barrier functions, and gut microbiome. Adv Drug Deliv Rev 2021;179:114021. [PMID: 34710529 DOI: 10.1016/j.addr.2021.114021] [Reference Citation Analysis]
67 Ozberk V, Reynolds S, Huo Y, Calcutt A, Eskandari S, Dooley J, Mills JL, Rasmussen IS, Dietrich J, Pandey M, Good MF. Prime-Pull Immunization with a Bivalent M-Protein and Spy-CEP Peptide Vaccine Adjuvanted with CAF®01 Liposomes Induces Both Mucosal and Peripheral Protection from covR/S Mutant Streptococcus pyogenes. mBio 2021;12:e03537-20. [PMID: 33622722 DOI: 10.1128/mBio.03537-20] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
68 Jing H, Yong L, Haiyan L, Yanjun M, Yun X, Yu Z, Taiming L, Rongyue C, Liang J, Jie W, Li Z, Jingjing L. Oral administration of Lactococcus lactis delivered heat shock protein 65 attenuates atherosclerosis in low-density lipoprotein receptor-deficient mice. Vaccine 2011;29:4102-9. [DOI: 10.1016/j.vaccine.2011.03.105] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 2.5] [Reference Citation Analysis]
69 Matzinger P, Kamala T. Tissue-based class control: the other side of tolerance. Nat Rev Immunol. 2011;11:221-230. [PMID: 21350581 DOI: 10.1038/nri2940] [Cited by in Crossref: 233] [Cited by in F6Publishing: 225] [Article Influence: 21.2] [Reference Citation Analysis]
70 Jones A, Bosio C, Duffy A, Goodyear A, Schriefer M, Dow S. Protection against pneumonic plague following oral immunization with a non-replicating vaccine. Vaccine 2010;28:5924-9. [PMID: 20600517 DOI: 10.1016/j.vaccine.2010.06.020] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.4] [Reference Citation Analysis]
71 Scherließ R, Mönckedieck M, Young K, Trows S, Buske S, Hook S. First in vivo evaluation of particulate nasal dry powder vaccine formulations containing ovalbumin in mice. Int J Pharm 2015;479:408-15. [PMID: 25595389 DOI: 10.1016/j.ijpharm.2015.01.015] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 2.1] [Reference Citation Analysis]
72 Pniewski T, Milczarek M, Wojas-turek J, Pajtasz-piasecka E, Wietrzyk J, Czyż M. Plant lyophilisate carrying S-HBsAg as an oral booster vaccine against HBV. Vaccine 2018;36:6070-6. [DOI: 10.1016/j.vaccine.2018.09.006] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 3.3] [Reference Citation Analysis]
73 Feng T, Elson CO, Cong Y. Treg cell-IgA axis in maintenance of host immune homeostasis with microbiota. Int Immunopharmacol. 2011;11:589-592. [PMID: 21111079 DOI: 10.1016/j.intimp.2010.11.016] [Cited by in Crossref: 24] [Cited by in F6Publishing: 27] [Article Influence: 2.0] [Reference Citation Analysis]
74 Basset C, Thiam F, Martino CD, Holton J, Clements JD, Kohli E. Cholera-like enterotoxins and Regulatory T cells. Toxins (Basel) 2010;2:1774-95. [PMID: 22069660 DOI: 10.3390/toxins2071774] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
75 Wang N, Wang T, Zhang M, Chen R, Niu R, Deng Y. Mannose derivative and lipid A dually decorated cationic liposomes as an effective cold chain free oral mucosal vaccine adjuvant-delivery system. Eur J Pharm Biopharm 2014;88:194-206. [PMID: 24769065 DOI: 10.1016/j.ejpb.2014.04.007] [Cited by in Crossref: 57] [Cited by in F6Publishing: 47] [Article Influence: 7.1] [Reference Citation Analysis]
76 Karussis D, Teitelbaum D, Sicsic C, Brenner T. Long-term treatment of multiple sclerosis with glatiramer acetate: Natural history of the subtypes of anti-glatiramer acetate antibodies and their correlation with clinical efficacy. Journal of Neuroimmunology 2010;220:125-30. [DOI: 10.1016/j.jneuroim.2010.01.009] [Cited by in Crossref: 37] [Cited by in F6Publishing: 30] [Article Influence: 3.1] [Reference Citation Analysis]
77 Kapusta J, Pniewski T, Wojciechowicz J, Bociag P, Płucienniczak A. Nanogram doses of alum-adjuvanted HBs antigen induce humoral immune response in mice when orally administered. Arch Immunol Ther Exp (Warsz) 2010;58:143-51. [PMID: 20165988 DOI: 10.1007/s00005-010-0065-2] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
78 Pniewski T, Kapusta J, Bociąg P, Wojciechowicz J, Kostrzak A, Gdula M, Fedorowicz-Strońska O, Wójcik P, Otta H, Samardakiewicz S, Wolko B, Płucienniczak A. Low-dose oral immunization with lyophilized tissue of herbicide-resistant lettuce expressing hepatitis B surface antigen for prototype plant-derived vaccine tablet formulation. J Appl Genet 2011;52:125-36. [PMID: 21107787 DOI: 10.1007/s13353-010-0001-5] [Cited by in Crossref: 56] [Cited by in F6Publishing: 46] [Article Influence: 4.7] [Reference Citation Analysis]
79 Vitelli A, Folgori A, Scarselli E, Colloca S, Capone S, Nicosia A. Chimpanzee adenoviral vectors as vaccines - challenges to move the technology into the fast lane. Expert Rev Vaccines 2017;16:1241-52. [PMID: 29047309 DOI: 10.1080/14760584.2017.1394842] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 5.2] [Reference Citation Analysis]
80 Yu M, Vajdy M. Mucosal HIV transmission and vaccination strategies through oral compared with vaginal and rectal routes. Expert Opin Biol Ther 2010;10:1181-95. [PMID: 20624114 DOI: 10.1517/14712598.2010.496776] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 2.2] [Reference Citation Analysis]
81 Batista-duharte A, Portuondo D, Pérez O, Carlos IZ. Systemic immunotoxicity reactions induced by adjuvanted vaccines. International Immunopharmacology 2014;20:170-80. [DOI: 10.1016/j.intimp.2014.02.033] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 2.4] [Reference Citation Analysis]
82 Kuo-Haller P, Cu Y, Blum J, Appleton JA, Saltzman WM. Vaccine delivery by polymeric vehicles in the mouse reproductive tract induces sustained local and systemic immunity. Mol Pharm 2010;7:1585-95. [PMID: 20698574 DOI: 10.1021/mp100009e] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
83 Feng T, Elson CO. Adaptive immunity in the host-microbiota dialog. Mucosal Immunol. 2011;4:15-21. [PMID: 20944557 DOI: 10.1038/mi.2010.60] [Cited by in Crossref: 70] [Cited by in F6Publishing: 64] [Article Influence: 5.8] [Reference Citation Analysis]
84 Lee JS, Yoon S, Han SJ, Kim ED, Kim J, Shin HS, Seo KY. Eyedrop vaccination: an immunization route with promises for effective responses to pandemics. Expert Rev Vaccines 2021;:1-11. [PMID: 34788181 DOI: 10.1080/14760584.2022.2008246] [Reference Citation Analysis]
85 Herich R. Is the role of IgA in local immunity completely known? Food and Agricultural Immunology 2017;28:223-37. [DOI: 10.1080/09540105.2016.1258547] [Cited by in Crossref: 16] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
86 Svärd A, Kastbom A, Sommarin Y, Skogh T. Salivary IgA antibodies to cyclic citrullinated peptides (CCP) in rheumatoid arthritis. Immunobiology 2013;218:232-7. [DOI: 10.1016/j.imbio.2012.04.011] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.7] [Reference Citation Analysis]
87 Ye L, Zeng R, Bai Y, Roopenian DC, Zhu X. Efficient mucosal vaccination mediated by the neonatal Fc receptor. Nat Biotechnol 2011;29:158-63. [PMID: 21240266 DOI: 10.1038/nbt.1742] [Cited by in Crossref: 108] [Cited by in F6Publishing: 101] [Article Influence: 9.8] [Reference Citation Analysis]
88 Lundberg SS, McNeilly TN, McAnulty RW, Greer AW. Attempts to induce tolerance to Trichostrongylus colubriformis infection in sheep. Parasite Immunol 2020;42:e12776. [PMID: 32672355 DOI: 10.1111/pim.12776] [Reference Citation Analysis]
89 del Rio B, Seegers JF, Gomes-Solecki M. Immune response to Lactobacillus plantarum expressing Borrelia burgdorferi OspA is modulated by the lipid modification of the antigen. PLoS One 2010;5:e11199. [PMID: 20585451 DOI: 10.1371/journal.pone.0011199] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
90 Tada R, Ogasawara M, Yamanaka D, Sakurai Y, Negishi Y, Kiyono H, Ohno N, Kunisawa J, Aramaki Y. Enzymatically polymerised polyphenols prepared from various precursors potentiate antigen-specific immune responses in both mucosal and systemic compartments in mice. PLoS One 2021;16:e0246422. [PMID: 33556119 DOI: 10.1371/journal.pone.0246422] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
91 Rahimian N, Miraei HR, Amiri A, Ebrahimi MS, Nahand JS, Tarrahimofrad H, Hamblin MR, Khan H, Mirzaei H. Plant-based vaccines and cancer therapy: Where are we now and where are we going? Pharmacol Res 2021;169:105655. [PMID: 34004270 DOI: 10.1016/j.phrs.2021.105655] [Reference Citation Analysis]
92 Corthésy B, Bioley G. Lipid-Based Particles: Versatile Delivery Systems for Mucosal Vaccination against Infection. Front Immunol 2018;9:431. [PMID: 29563912 DOI: 10.3389/fimmu.2018.00431] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 8.3] [Reference Citation Analysis]
93 Russell MW, Mestecky J. Tolerance and protection against infection in the genital tract. Immunol Invest 2010;39:500-25. [PMID: 20450289 DOI: 10.3109/08820131003674834] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 1.7] [Reference Citation Analysis]
94 Cong Y, Feng T, Fujihashi K, Schoeb TR, Elson CO. A dominant, coordinated T regulatory cell-IgA response to the intestinal microbiota. Proc Natl Acad Sci USA. 2009;106:19256-19261. [PMID: 19889972 DOI: 10.1073/pnas.0812681106] [Cited by in Crossref: 296] [Cited by in F6Publishing: 270] [Article Influence: 22.8] [Reference Citation Analysis]
95 Budimir N, de Haan A, Meijerhof T, Gostick E, Price DA, Huckriede A, Wilschut J. Heterosubtypic cross-protection induced by whole inactivated influenza virus vaccine in mice: influence of the route of vaccine administration. Influenza Other Respir Viruses 2013;7:1202-9. [PMID: 24102979 DOI: 10.1111/irv.12142] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 2.1] [Reference Citation Analysis]
96 Fragoso-Saavedra M, Vega-López MA. Induction of mucosal immunity against pathogens by using recombinant baculoviral vectors: Mechanisms, advantages, and limitations. J Leukoc Biol 2020;108:835-50. [PMID: 32392638 DOI: 10.1002/JLB.4MR0320-488R] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
97 Hirschberg HJ, van de Wijdeven GG, Kraan H, Amorij J, Kersten GF. Bioneedles as alternative delivery system for hepatitis B vaccine. Journal of Controlled Release 2010;147:211-7. [DOI: 10.1016/j.jconrel.2010.06.028] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 2.7] [Reference Citation Analysis]
98 Xing L, Zhou T, Fan Y, He Y, Pang T, Cho K, Lu J, Jiang H, Cho C. Efficient Mucosal Immunization by Mucoadhesive and pH-Sensitive Polymeric Vaccine Delivery System. Macromol Res 2019;27:215-26. [DOI: 10.1007/s13233-019-7042-3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
99 Kim HJ, Lee JY, Kang HA, Lee Y, Park EJ, Kim HJ. Oral immunization with whole yeast producing viral capsid antigen provokes a stronger humoral immune response than purified viral capsid antigen. Lett Appl Microbiol 2014;58:285-91. [PMID: 24251903 DOI: 10.1111/lam.12188] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 2.8] [Reference Citation Analysis]
100 Krause A, Whu WZ, Xu Y, Joh J, Crystal RG, Worgall S. Protective anti-Pseudomonas aeruginosa humoral and cellular mucosal immunity by AdC7-mediated expression of the P. aeruginosa protein OprF. Vaccine 2011;29:2131-9. [PMID: 21215829 DOI: 10.1016/j.vaccine.2010.12.087] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 2.3] [Reference Citation Analysis]
101 Bioley G, Monnerat J, Lötscher M, Vonarburg C, Zuercher A, Corthésy B. Plasma-Derived Polyreactive Secretory-Like IgA and IgM Opsonizing Salmonella enterica Typhimurium Reduces Invasion and Gut Tissue Inflammation through Agglutination. Front Immunol 2017;8:1043. [PMID: 28900429 DOI: 10.3389/fimmu.2017.01043] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 3.8] [Reference Citation Analysis]
102 Gómez-Zafra MJ, Navas A, Jojoa J, Murillo J, González C, Gómez MA. Immune Profile of the Nasal Mucosa in Patients with Cutaneous Leishmaniasis. Infect Immun 2020;88:e00881-19. [PMID: 32094254 DOI: 10.1128/IAI.00881-19] [Reference Citation Analysis]
103 Demberg T, Robert-Guroff M. Mucosal immunity and protection against HIV/SIV infection: strategies and challenges for vaccine design. Int Rev Immunol 2009;28:20-48. [PMID: 19241252 DOI: 10.1080/08830180802684331] [Cited by in Crossref: 52] [Cited by in F6Publishing: 50] [Article Influence: 4.0] [Reference Citation Analysis]
104 Aran K, Chooljian M, Paredes J, Rafi M, Lee K, Kim AY, An J, Yau JF, Chum H, Conboy I, Murthy N, Liepmann D. An oral microjet vaccination system elicits antibody production in rabbits. Sci Transl Med 2017;9:eaaf6413. [PMID: 28275153 DOI: 10.1126/scitranslmed.aaf6413] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 4.4] [Reference Citation Analysis]
105 Thiam F, Martino CD, Bon F, Charpilienne A, Cachia C, Poncet D, Clements JD, Basset C, Kohli E. Unexpected modulation of recall B and T cell responses after immunization with rotavirus-like particles in the presence of LT-R192G. Toxins (Basel) 2010;2:2007-27. [PMID: 22069670 DOI: 10.3390/toxins2082007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
106 Hasselberg A, Ekman L, Yrlid LF, Schön K, Lycke NY. ADP-ribosylation controls the outcome of tolerance or enhanced priming following mucosal immunization. J Immunol 2010;184:2776-84. [PMID: 20142362 DOI: 10.4049/jimmunol.0901445] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
107 Chaudhary O, Wang L, Bose D, Narayan V, Yeh MT, Carville A, Clements JD, Andino R, Kozlowski PA, Aldovini A. Comparative Evaluation of Prophylactic SIV Vaccination Modalities Administered to the Oral Cavity. AIDS Res Hum Retroviruses 2020;36:984-97. [PMID: 32962398 DOI: 10.1089/AID.2020.0157] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
108 Pniewski T. The twenty-year story of a plant-based vaccine against hepatitis B: stagnation or promising prospects? Int J Mol Sci 2013;14:1978-98. [PMID: 23337199 DOI: 10.3390/ijms14011978] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]